| 09/30/2024 15:00 |
Monthly Sales Report, September FY2024 |
| 09/24/2024 15:00 |
Approval of New Drug Application (NDA) of Firdapse Tablet 10mg Acquired by Consolidated Subsidiary |
| 09/13/2024 16:45 |
Notice Regarding Disposal of Treasury Shares as Restricted Stock Incentives for Employee Shareholding Association |
| 08/30/2024 15:00 |
Monthly Sales Report, August FY2024 |
| 08/27/2024 15:00 |
Summary of Financial Results for the second quarter 2025 |
| 08/27/2024 15:00 |
Announcement of Consolidated Financial Forecasts for FY2024 |
| 08/27/2024 15:00 |
FY2024(Year Ending January 20, 2025) 2nd Quarter Financial Highlights |
| 07/31/2024 15:00 |
Monthly Sales Report, July FY2024 |
| 06/28/2024 15:00 |
Monthly Sales Report, June FY2024 |
| 05/31/2024 15:00 |
Monthly Sales Report, May FY2024 |
| 05/27/2024 15:00 |
Summary of Financial Results for the first quarter 2025 |
| 05/27/2024 15:00 |
FY2024 (Year Ending January 20, 2025) 1st Quarter Financial Highlights |
| 05/15/2024 15:00 |
Notice Regarding Completion of Payment for Disposal of Treasury Stock for Restricted-Stock-Based Compensation |
| 04/30/2024 15:00 |
Monthly Sales Report, April FY2024 |
| 04/17/2024 11:00 |
Corporate Governance Report |
| 04/16/2024 16:00 |
Notice Regarding Disposal of Treasury Stock for Restricted-Stock-Based Compensation |
| 04/16/2024 16:00 |
Notice Regarding Changes in the Chairperson and Member of the Nominating and Compensation Committee |
| 03/29/2024 15:00 |
Monthly Sales Report, March FY2024 |
| 03/26/2024 08:00 |
Notice of Convocation of the 49th Annual General Meeting of Shareholders |
| 03/15/2024 15:00 |
Overview of the Results of an Evaluation of the Effectiveness of the Board of Directors |
| 03/01/2024 15:00 |
Summary of Financial Results 2024 |
| 03/01/2024 15:00 |
FY2023 Financial Highlights |
| 03/01/2024 15:00 |
FY2023 Supplementary Material for Financial Results |
| 02/29/2024 15:00 |
Notice Concerning Completion of Acquisition of Shares in Wosana S.A., Making it a Subsidiary |
| 02/29/2024 15:00 |
Monthly Sales Report, February FY2024 |
| 02/15/2024 16:00 |
Notice on the Recognition of Deferred Tax Assets and Revision of Full-Year Earnings Forecasts |
| 01/31/2024 15:00 |
Monthly Sales Report, January FY2023 |
| 01/15/2024 16:00 |
Corporate Governance Report |
| 12/29/2023 15:00 |
Monthly Sales Report, December FY2023 |
| 12/21/2023 15:30 |
Announcement of Acquisition of Shares in Wosana S.A., Making it a Subsidiary |
| 12/15/2023 15:00 |
Notice regarding Stock Split, partial amendment to the Articles of Incorporation, and Shareholder Benefits Program |
| 11/30/2023 15:00 |
Monthly Sales Report, November FY2023 |
| 11/27/2023 16:00 |
Summary of Financial Results for the third quarter 2024 |
| 11/27/2023 16:00 |
Revision to Consolidated Financial Forecasts for FY2023 |
| 11/27/2023 16:00 |
FY2023 (Year Ending January 20, 2024) 3rd Quarter Financial Highlights |
| 10/31/2023 15:00 |
Monthly Sales Report, October FY2023 |
| 10/10/2023 13:00 |
Announcement of Analyst Report Release by Shared Research Inc. |
